MedPath

BIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

BIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

1211575002

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Oct 27, 2021

Dosage Form

SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211575002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BIMEKIZUMABActive
Quantity: 160 mg
Name: BIMEKIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AC
L04AC21

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.